Your browser doesn't support javascript.
loading
MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production.
Mok, Yingting; Schwierzeck, Vera; Thomas, David C; Vigorito, Elena; Rayner, Tim F; Jarvis, Lorna B; Prosser, Haydn M; Bradley, Allan; Withers, David R; Mårtensson, Inga-Lill; Corcoran, Lynn M; Blenkiron, Cherie; Miska, Eric A; Lyons, Paul A; Smith, Kenneth G C.
Afiliação
  • Mok Y; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Schwierzeck V; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Thomas DC; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Vigorito E; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
  • Rayner TF; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Jarvis LB; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Prosser HM; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Bradley A; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Withers DR; MRC Centre for Immune Regulation, Institute for Biomedical Research, University of Birmingham, B15 2TT, UK.
  • Mårtensson IL; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Corcoran LM; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.
  • Blenkiron C; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK.
  • Miska EA; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK.
  • Lyons PA; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
  • Smith KGC; Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
J Immunol ; 191(6): 3037-3048, 2013 Sep 15.
Article em En | MEDLINE | ID: mdl-23960236
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Linfócitos B / Ativação Linfocitária / MicroRNAs / Fator 2 de Transcrição de Octâmero Limite: Animals Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Linfócitos B / Ativação Linfocitária / MicroRNAs / Fator 2 de Transcrição de Octâmero Limite: Animals Idioma: En Ano de publicação: 2013 Tipo de documento: Article